Oxidative stress response of tumor cells: Microarray-based comparison between artemisinins and anthracyclines

Biochemical Pharmacology

Volumn 68, Issue 1, 2004, Pages 3-10

  Efferth, Thomas ^a   Oesch, Franz ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

AD32; ARE; ARM; ARS; ART; arteether; artemether; ARTEMIS; artemisinin; artemisitene; ARTEST1 2; artesunate; daunorubicin; deoxydoxorubicin; dihydroartemisinyl ester stereoisomers 1 2; DNR; DODOX; DOX; doxorubicin; EPI; trifluoroacetyl doxorubicin 14 valerate

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEETHER; ARTEMISININ DERIVATIVE; ARTEMISITENE; ARTESUNATE; DAUNORUBICIN; DEOXYDOXORUBICIN; DIHYDROARTEMISININ DERIVATIVE; DOXORUBICIN; EPIRUBICIN; ESTER DERIVATIVE; IDARUBICIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CLUSTER ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DATA BASE; DNA MICROARRAY; EXPERIMENTAL TEST; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; IC 50; IMAGE ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STEREOISOMERISM; TUMOR CELL; UNITED STATES;

ANIMALS; ANTHRACYCLINES; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; ARTEMISININS; CLUSTER ANALYSIS; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION PROFILING; HUMANS; INHIBITORY CONCENTRATION 50; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RNA, MESSENGER; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 2942624053     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.03.003     Document Type: Article

References (30)

1. Borstnik K., Paik I., Shapiro T.A., Posner G.H. Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds. Int. J. Parasitol. 32:2002;1661-1667
2. Bustos M.D., Gay F., Diquet B. In vitro test on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qingahaosu derivatives. Bull. World Health Organ. 72:1994;729-735
3. Posner G.H., Paik I.H., Sur S., McRiner A.J., Bortnik K., Xie S., et al. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. J. Med. Chem. 46:2003;1060-1065
4. Woerdenbag H.J., Moskal T.A., Pras N., Malingre T.M., el-Feraly F.S., Kampinga H.H., et al. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J. Nat. Prod. 56:1993;849-856
5. Efferth T., Riicker G., Falkenberg M., Manns D., Olbrich A., Fabry U., et al. Detection of apoptosis in KG-la leukemic cells treated with investigational drugs. Arzneimittelforschung. 46:1996;196-200
6. Efferth T., Dustan H., Sauerbrey A., Miyachi H., Chitambar C.R. The antimalarial artesunate is also active against cancer. Int. J. Oncol. 18:2001;767-773
7. Efferth T., Sauerbrey A., Olbrich A., Gebhart E., Rauch P., Weber H.O., et al. Molecular modes of action of artesunate in tumor cell lines. Mol. Pharmacol. 64:2003;382-394
8. Efferth T., Marschall M., Wang X., Huong S.-M., Hauber I., Olbrich A., et al. Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegaloviruses. J. Mol. Med. 80:2002;223-224
9. Balint G.A. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol. Ther. 90:2001;261-265
10. Ribeiro I.R., Olliaro P. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med. Trop. (Mars). 58:1998;50-53
11. Meshnick S.R., Yang Y.Z., Lima V., Kuypers F., Kamchonwongpaisan S., Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother. 37:1993;1108-1114
12. Posner G.H., Oh C.H. A region specifically oxygen-18 labeled 1, 2, 4-trioxane: a simple chemical model system to probe the mechanism(s) for the antimalarial activity of artemisinin (qinhaosu). J. Am. Chem. Soc. 114:1992;8328-8329
13. Posner G.H., Oh C.H., Wang D., Gerena L., Milhous W.K., Meshnick S.R., et al. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. J. Med. Chem. 37:1994;1256-1258
14. Krungkrai S.R., Yuthavong Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans. R. Soc. Trop. Med. Hyg. 81:1987;710-714
15. Rajagopalan S., Politi P.M., Sinha B.K., Myers C.E. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 48:1988;4766-4769
16. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57:1999;727-741
17. Dayan A.D. Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use? Med. Trop. (Mars). 58(3 Suppl):1998;32-37
18. Scherf U., Ross D.T., Waltham M., Smith L.H., Lee J.K., Tanabe L., et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24:2000;236-244
19. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601
20. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst. 82:1990;1113-1118
21. Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 9:1990;811-818
22. Keselman H.J., Cribbie R., Holland B. Controlling the rate of Type I error over a large set of statistical tests. Br. J. Math. Stat. Psychol. 55:2002;27-39
23. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 19:2003;368-375
24. Efferth T., Fabry U., Osieka R. Apoptosis and resistance to daunorubicin in human leukemic cells. Leukemia. 11:1997;1180-1186
25. Volm M., Koomagi R., Mattern J., Efferth T. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br. J. Cancer. 87:2002;251-257
26. Batty K.T., Davis T.M., Thu L.T., Binh T.Q., Anh T.K., Ilett K.F. Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria. J. Chromatogr. B. Biomed. Appl. 677:1996;345-350
27. Meshnick S.R. Artemisinin: mechanisms of action, resistance and toxicity. Int. J. Parasitol. 32:2002;1655-1660
28. Gridelli C. 5-HT3-receptor antagonists in the control of delayed-onset emesis. Anticancer Res. 23:2003;2773-2782
29. Kang Y.R. Molecular and cellular mechanisms of cardiotoxicity. Environ. Health Perspect. 109(Suppl 1):2001;27-34
30. Kang Y.R. New understanding in cardiotoxicity. Curr. Opin. Drug Discov. Dev. 6:2003;110-116